| Candesartan cilexetil: an update. | |
| | |
MedLine Citation:
|
PMID: 21651457 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Introduction: Candesartan cilexetil is one of the most often-used first-line drugs regarding the management of arterial hypertension. Moreover, this drug has proven its effectiveness in chronic heart failure and exerts beneficial effects in diabetes, stroke, dementia and atrial fibrillation. Areas covered: This review focuses on the use of candesartan cilexetil in Phase II and Phase III trials and their implications for clinical usage in the treatment of arterial hypertension and heart failure. The usage of candesartan cilexetil in patients with stroke, migraine or atrial fibrillation, hypertrophy obstructive or nonobstructive cardiomyopathy and diabetic or non diabetic renal diseases will be discussed. Relevant publications were identified by an extensive Medline search. Expert opinion: Candesartan cilexetil is a highly effective ARB for the treatment of arterial hypertension and heart failure. Also, recent trials have suggested beneficial effects in diabetic patients, patients with nondiabetic renal diseases, stroke, migraine and atrial fibrillation. |
| | |
Authors:
|
Alexander Joost; Heribert Schunkert; Peter Walter Radke |
Related Documents
:
|
7988307 - Different change in lipoprotein(a) levels from lipid levels of other lipoproteins with ... 10323767 - Endothelial cell dysfunction and arterial wall hypertrophy are associated with disturbe... 18803987 - Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-n... 10230557 - Occult hypoglycemia caused by hemodialysis. 19308337 - Tea consumption and risk of type 2 diabetes: a meta-analysis of cohort studies. 8089637 - Streptococcal endocarditis treated with two-week antibiotic regimen: preliminary report... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-6-9 |
Journal Detail:
|
Title: Expert opinion on pharmacotherapy Volume: - ISSN: 1744-7666 ISO Abbreviation: - Publication Date: 2011 Jun |
Date Detail:
|
Created Date: 2011-6-9 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100897346 Medline TA: Expert Opin Pharmacother Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Medizinische Klinik II, Universität zu Lübeck, Ratzeburger Allee 160, 23538 Lübeck , Germany +49 451 500 2421 ; +49 451 500 2363 ; peter.radke@uk-sh.de. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Combination perindopril/indapamide for the treatment of hypertension: A review.
Next Document: Tumor necrosis factor biologics beyond psoriasis in dermatology.